Frontiers in immunology2026ReviewDrug Delivery
Di Domenico O, Marrapodi Mm, Di Feo G, Argenziano L, Rossi F, Di Paola A
Pediatric immune thrombocytopenia (ITP) is an acquired immune-mediated disorder triggered by autoantibody production directed against glycoproteins on the platelet surface, leading to platelet destruction in the spleen and impaired megakaryopoiesis in the bone marrow. The immune response is further compromised by a…
Read the article →Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2026ReviewDrug Delivery
Pan Y, Wang R, Qin S, Zhao L, Xing X
Curcumin has diverse pharmacological activities but poor water solubility, rapid degradation, extensive metabolism, and very low oral bioavailability limit its therapeutic use. This review evaluates mesenchymal stem cell-derived exosomes (MSC-Exo; MSC-derived small extracellular vesicles per MISEV2023) as natural…
Read the article →Molecules (Basel, Switzerland)2026ReviewDrug Delivery
Lee M, Choi Y, Yoon Sj, Kim M
Extracellular vesicles (EVs) have emerged as promising therapeutic carriers owing to their biocompatibility, low immunogenicity, and ability to transport diverse biological cargo. However, successful EV-based therapy depends not only on carrier engineering but also on selecting an administration route appropriate for…
Read the article →Frontiers in oncology2026ReviewDrug Delivery
Beaugé L, Ibarra Le
Photo-assisted therapies have emerged as promising strategies for cancer treatment by combining localized tumor ablation with the induction of systemic antitumor immune responses. Despite encouraging preclinical and clinical advances, their therapeutic efficacy remains limited by the unfavorable pharmacokinetics…
Read the article →Translational research : the journal of laboratory and clinical medicine2026ReviewDrug Delivery
Kausar T, Ahmed W, Shafiq T, Kausar R, Liang Y, Duan L
Nanomedicine represents one of the pivotal technologies that further bridges critical gaps in precision theranostics through targeted delivery, integrated diagnostics and therapeutics, and personalized treatment. Among various nanocarriers, extracellular vesicles (EVs) have attracted substantial interest owing to…
Read the article →International journal of nanomedicine2026ReviewDrug Delivery
Li X, Yu Y, Xie Y, He P, Chen Y, Guo Z, Et Al.
Macrophages are highly plastic immune cells with tumor-homing capacity and immunomodulatory functions, making macrophage-based nanoplatforms attractive for cancer immunotherapy. Macrophage-based nanoplatforms include macrophage-derived extracellular vesicles (EVs), macrophage membrane-coated nanoparticles, and live…
Read the article →International Journal of Pharmaceutics.2017ReviewNon-viral Gene Delivery
RNA interference (RNAi) therapeutics have shown potential for treating genetic, viral, and cancerous diseases, but the main bottleneck remains delivery of functional RNA molecules into the cell cytoplasm. The review focuses on liposomes and other lipid carriers, and on exosomes/extracellular vesicles (EVs), as…
Read the article →